Published in Arch Intern Med on June 25, 2001
How I treat cobalamin (vitamin B12) deficiency. Blood (2008) 1.87
Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr (2011) 1.63
Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr (2011) 1.43
Mandatory fortification of the food supply with cobalamin: an idea whose time has not yet come. J Inherit Metab Dis (2010) 0.83
A new 13C breath test to detect vitamin B12 deficiency: a prevalent and poorly diagnosed health problem. J Breath Res (2011) 0.76
Holotranscobalamin is a useful marker of vitamin B12 deficiency in alcoholics. ScientificWorldJournal (2012) 0.76
Cobalamin deficiency in elderly patients. CMAJ (2005) 0.75
Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the Literature. Case Rep Med (2017) 0.75
Methylmalonic acid and clinical practice. Arch Intern Med (2002) 0.75
Homocysteine, Cobalamin and Folate Status and their Relations to Neurocognitive and Psychological Markers in Elderly in Northeasten of Iran. Iran J Basic Med Sci (2013) 0.75
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol (1996) 1.60
Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry (1986) 1.53
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG) Br J Haematol (1991) 1.45
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology (1984) 1.38
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38
[Diagnosis and vitamin B12 deficiency]. Tidsskr Nor Laegeforen (2001) 1.38
Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc Natl Acad Sci U S A (1980) 1.35
Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut (1986) 1.23
Effect of the cobalt-N coordination on the cobamide recognition by the human vitamin B12 binding proteins intrinsic factor, transcobalamin and haptocorrin. Eur J Biochem (1991) 1.22
Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J Biol Chem (1999) 1.21
Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc Natl Acad Sci U S A (1996) 1.17
Isolation of the human placenta receptor for epidermal growth factor-urogastrone. Nature (1979) 1.15
Epidermal growth factor inhibits cysteamine-induced duodenal ulcers. Gastroenterology (1983) 1.15
PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis. Clin Exp Immunol (1977) 1.08
Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology (1988) 1.07
Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal EGF. Scand J Gastroenterol (1983) 1.05
Volume of blood removed for analytical purposes during hospitalization of low-birthweight infants. Clin Chem (1981) 1.04
Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone. J Biol Chem (1980) 1.00
Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry (1988) 1.00
Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol (1987) 0.99
Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology (1986) 0.99
C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest (1998) 0.98
Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Scand J Clin Lab Invest (2003) 0.96
A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genet Cytogenet (1994) 0.96
Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest (2004) 0.95
Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med (2003) 0.94
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer (1998) 0.94
Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands. Gut (1984) 0.94
Renal origin of rat urinary epidermal growth factor. Regul Pept (1984) 0.93
Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol (1993) 0.93
Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod (2005) 0.92
Conformational changes of transcobalamin induced by aquocobalamin binding. Mechanism of substitution of the cobalt-coordinated group in the bound ligand. J Biol Chem (2000) 0.92
Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leuk Res (1984) 0.91
Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome. Br J Haematol (1992) 0.91
Holotranscobalamin - a sensitive marker of cobalamin malabsorption. Eur J Clin Invest (1999) 0.91
Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut (1998) 0.90
Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res (2000) 0.90
Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol (1976) 0.90
Characterization of the particulate and soluble acceptor for transcobalamin II from human placenta and rabbit liver. Biochim Biophys Acta (1980) 0.89
Transcobalamin from cow milk: isolation and physico-chemical properties. Biochim Biophys Acta (1996) 0.89
Antibody response to pneumococcal vaccine in splenectomized adults and adolescents. Acta Pathol Microbiol Immunol Scand C (1982) 0.89
Variation with age of reference values for P-cobalamins. Scand J Haematol (1983) 0.88
Epidermal growth factor transcription, translation, and signal transduction by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol (1992) 0.88
Unsaturated and cobalamin saturated transcobalamin I and II in normal human plasma. Scand J Clin Lab Invest (1977) 0.87
Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem (2001) 0.87
The cellular immune response after splenectomy in humans. Impaired immunoglobulin synthesis in vitro. Scand J Haematol (1983) 0.86
Cobalamin binding proteins in human seminal plasma. Scand J Clin Lab Invest (1992) 0.86
In vitro parameters of cell-mediated immune reactions in healthy individuals following immune-stimulation attempts with levamisole. Acta Allergol (1975) 0.86
Quantification of melanoma cell-specific MART-1 mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR. Clin Chem (2000) 0.86
Binding of cobalamin and cobinamide to transcobalamin from bovine milk. Biochemistry (1995) 0.86
13-cis retinoic acid treatment of myelodysplastic syndromes. Leuk Res (1987) 0.86
The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med (2000) 0.86
Synthesis and secretion of a cobalamin-binding protein by HT 29 cell line. Biochem J (1991) 0.86
Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate. J Urol (1997) 0.85
A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer (1995) 0.85
Adrenergic effects on exocrine secretion of rat submandibular epidermal growth factor. Gut (1984) 0.85
ATP-ase activity of purified human normal T- and B-lymphocytes. Scand J Haematol (1978) 0.85
Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents. Br J Pharmacol (2006) 0.84
Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor. Pediatr Res (1995) 0.84
Vasoactive intestinal polypeptide and acetylcholine stimulate exocrine secretion of epidermal growth factor from the rat submandibular gland. Regul Pept (1986) 0.84
Characterization and immunohistochemical localization of rat salivary cobalamin-binding protein and comparison with human salivary haptocorrin. Biochim Biophys Acta (1985) 0.84
Transcellular transport of vitamin B(12) in LLC-PK1 renal proximal tubule cells. J Am Soc Nephrol (2001) 0.84
Breast tumour as a first manifestation of extramedullary relapse in acute lymphoblastic leukaemia. Scand J Haematol (1984) 0.84
Determination of cobalamins in biological material. II. The cobalamins in human plasma and erythrocytes after desalting on nonpolar adsorbent material, and separation by one-dimensional thin-layer chromatography. Anal Biochem (1983) 0.84
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol (1995) 0.83
A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies. Blood (1987) 0.83
Urinary excretion of epidermal growth factor and Tamm-Horsfall protein in three rat models with increased renal excretion of urine. Regul Pept (1997) 0.83
Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Infect Dis (1990) 0.83
Serum beta 2-microglobulin in acute and chronic leukaemia. Scand J Haematol (1980) 0.83
Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood (1986) 0.83
Processing of epidermal growth factor in the rat submandibular gland by Kallikrein-like enzymes. Growth Factors (1994) 0.83
Epidermal growth factor in the rat lung. Histochemistry (1991) 0.82
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. Br J Haematol (1995) 0.82
Calibrated user-friendly reverse transcriptase-PCR assay: quantitation of epidermal growth factor receptor mRNA. Clin Chem (1998) 0.82
Purification and characterization of rabbit haptocorrin. Biochim Biophys Acta (1981) 0.82
Structural homologies of cobalamin-binding proteins. Tryptic peptide mapping of intrinsic factor, transcobalamin and haptocorrin from man, hog and rabbit. Biochim Biophys Acta (1982) 0.82
Gingival status during chemical plaque control with or without prior mechanical plaque removal in patients with acute myeloid leukaemia. J Clin Periodontol (1992) 0.82
Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: the value of both internal and external standards. Anal Cell Pathol (1993) 0.82
Isolated gingival relapse in acute myeloid leukaemia. Eur J Haematol (1988) 0.82
Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer. Scand J Clin Lab Invest (1999) 0.82
Cobalamin and its binding protein in rat milk. Scand J Clin Lab Invest (1989) 0.82
Exocrine secretion of epidermal growth factor from Brunner's glands. Stimulation by VIP and acetylcholine. Regul Pept (1983) 0.81
Epidermal growth factor in urine from patients with urinary bladder tumors. Eur Urol (1988) 0.81
Adrenergic effects on secretion of amylase from the rat salivary glands. Digestion (1988) 0.81
Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol (1994) 0.81
Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol (1993) 0.81
Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabet Med (1989) 0.81
Distribution of i.v. administered epidermal growth factor in the rat. Regul Pept (1988) 0.81
Amphiregulin is expressed in primary cultures of prostate myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue. Prostate Cancer Prostatic Dis (1998) 0.81
Detection of splenosis and ectopic spleens with 99mTc-labelled heat damaged autologous erythrocytes in 90 splenectomized patients. Scand J Haematol (1981) 0.81
Monocyte cytotoxicity after splenectomy. Scand J Haematol (1981) 0.81
Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination. Acta Pathol Microbiol Immunol Scand C (1983) 0.80